GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » Cyclically Adjusted Book per Share

Kangmei Pharmaceutical Co (SHSE:600518) Cyclically Adjusted Book per Share : ¥3.09 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Kangmei Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2024 was ¥0.509. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.09 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Kangmei Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was -7.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -7.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -2.20% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Kangmei Pharmaceutical Co was 32.10% per year. The lowest was -7.00% per year. And the median was 22.80% per year.

As of today (2024-06-05), Kangmei Pharmaceutical Co's current stock price is ¥1.86. Kangmei Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥3.09. Kangmei Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 0.60.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kangmei Pharmaceutical Co was 15.82. The lowest was 0.46. And the median was 3.51.


Kangmei Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Kangmei Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Kangmei Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.86 3.91 3.57 3.42 3.15

Kangmei Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.35 3.27 3.23 3.15 3.09

Competitive Comparison of Kangmei Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Kangmei Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangmei Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kangmei Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kangmei Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Kangmei Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kangmei Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.509/115.2271*115.2271
=0.509

Current CPI (Mar. 2024) = 115.2271.

Kangmei Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.838 98.200 3.330
201409 2.947 98.900 3.434
201412 3.126 99.000 3.638
201503 3.315 99.900 3.824
201506 3.292 99.500 3.812
201509 3.441 100.500 3.945
201512 3.592 100.600 4.114
201603 3.796 102.200 4.280
201606 4.992 101.400 5.673
201609 5.162 102.400 5.809
201612 5.285 102.600 5.935
201703 5.494 103.200 6.134
201706 5.467 103.100 6.110
201709 5.678 104.100 6.285
201712 5.115 104.500 5.640
201803 6.139 105.300 6.718
201806 6.106 104.900 6.707
201809 6.364 106.600 6.879
201812 4.547 106.500 4.920
201903 5.116 107.700 5.474
201906 5.028 107.700 5.379
201909 5.018 109.800 5.266
201912 3.528 111.200 3.656
202003 3.729 112.300 3.826
202006 3.245 110.400 3.387
202009 3.055 111.700 3.151
202012 -2.715 111.500 -2.806
202103 -2.831 112.662 -2.895
202106 -2.898 111.769 -2.988
202109 -0.833 112.215 -0.855
202112 0.716 113.108 0.729
202203 0.708 114.335 0.714
202206 0.702 114.558 0.706
202209 0.652 115.339 0.651
202212 0.501 115.116 0.501
202303 0.498 115.116 0.498
202306 0.492 114.558 0.495
202309 0.491 115.339 0.491
202312 0.508 114.781 0.510
202403 0.509 115.227 0.509

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Kangmei Pharmaceutical Co  (SHSE:600518) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kangmei Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.86/3.09
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kangmei Pharmaceutical Co was 15.82. The lowest was 0.46. And the median was 3.51.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Kangmei Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000
Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.
Executives
Xu Dong Jin Director
Li Jian Hua senior management
Qiu Xi Wei Director
Wang Min senior management
Peng Qin senior management
Ma Xing Tian Director
Lin Guo Xiong senior management
Zhuang Yi Qing senior management
Wen Shao Sheng Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines